Provided by Tiger Trade Technology Pte. Ltd.

SIRNAOMICS-B

7.350
+0.0200.27%
Volume:73.90K
Turnover:543.34K
Market Cap:786.45M
PE:-11.08
High:7.400
Open:7.330
Low:7.300
Close:7.330
52wk High:22.780
52wk Low:2.830
Shares:107.00M
HK Float Shares:107.00M
Volume Ratio:0.51
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.663
ROE:-1188.81%
ROA:-39.84%
PB:-19.65
PE(LYR):-11.08
PS:105.99

Loading ...

Company Profile

Company Name:
SIRNAOMICS-B
Exchange:
SEHK
Establishment Date:
2007
Employees:
52
Office Location:
Hopewell Centre,46th Floor,183 Queen’s Road East,Wan Chai,Hong Kong
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Sirnaomics Ltd. is an investment holding company. The Company and its subsidiaries are clinical-stage biotechnology companies that are engaged in developing and commercializing ribonucleic acid interference (RNAi) technology and multiple therapeutics. The Company is engaged in discovering and developing drugs for indications with unmet medical needs in areas. Its lead clinical drug candidates include STP705 and STP707. Its STP705 is a multi-targeted siRNA therapeutic advancing clinical development across two oncology indications: squamous cell carcinoma in situ (isSCC) and basal cell carcinoma (BCC). Its STP707 is an intravenous siRNA therapeutic being evaluated in phase I clinical trial for multiple solid tumors, including colorectal, pancreatic, liver, and metastatic melanoma cancers. It is capitalizing on its dual delivery platforms, which include Polypeptide nanoparticle (PNP) and GalAhead.

Directors

Name
Position
PAN Hong Hui
Chairman of the Board,Executive Director,Member of the Nomination Committee
WANG Yu Shan
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Chairman,调查委员会委员
ZHANG Peng
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,调查委员会委员
LO Yee Hang
Independent Director,Chairman of the Nomination Committee,Audit Committee Member,调查委员会主席
OU Yang Yun Long
Director,Member of the Remuneration and Assessment Committee,Audit Committee Member
YAN Hui Jun
Director

Shareholders

Name
Position
PAN Hong Hui
CEO
YUAN Run Ting
Corporate Secretary
XIE Yong Ji
Other Senior Executives
Wang Edward Yongxiang
Other Senior Executives